如果这些结果能被将来的研究证实，那么血管加压素v 2受体拮抗剂可能将成为新的降压策略，尤其是适用黑人种群。
If these results are confirmed in further studies, then vasopressin V2 receptor antagonists might offer a novel antihypertensive strategy, especially in the black population.
本研究旨在评价血管加压素v 2受体拮抗剂的急性血流动力学效应。
This study sought to assess the acute hemodynamic effect of vasopressin V2 receptor antagonism.
结论：大鼠尾加压素II是大鼠肺主动脉有效的血管收缩剂，细胞信号转导通路MAPK的激活参与其收缩效应。
CONCLUSION: rat U-II was a potent vasoconstrictor of rat main pulmonary arteries and this response was mediated through MAPK.
应用推荐